{
  "id": "enwiki-001338600496",
  "slug": "pardoprunox",
  "title": "Pardoprunox",
  "qid": "",
  "lead": "Pardoprunox (INN; code name SLV-308) is an antiparkinsonian drug developed by Solvay for the treatment of Parkinson's disease that reached phase III clinical trials before being discontinued. It was also being investigated for the treatment of [[major depression|depression] and anxiety but these indications appear to have been abandoned as well. Pardoprunox acts as a D 2 (pK i = 8.1) and D 3 receptor (pK i = 8.6) partial agonist (IA = 50% and 67%, respectively) and 5-HT 1A receptor (pK i = 8.5) full agonist (IA = 100%). It also binds to D 4 (pK i = 7.8), α 1 -adrenergic (pK i = 7.8), α 2 -adrenergic (pK i = 7.4), and 5-HT 7 receptors (pK i = 7.2) with lower affinity. Relative to other dopaminergic antiparkinsonian agents, pardoprunox is thought to have significantly less of a propensity for inducing certain side effects like dyskinesia and psychosis.",
  "body": "Pardoprunox (INN; code name SLV-308) is an antiparkinsonian drug developed by Solvay for the treatment of Parkinson's disease that reached phase III clinical trials before being discontinued. [http://adisinsight.springer.com/drugs/800014329] It was also being investigated for the treatment of depression and anxiety but these indications appear to have been abandoned as well. Pardoprunox acts as a D 2 (pK i = 8.1) and D 3 receptor (pK i = 8.6) partial agonist (IA = 50% and 67%, respectively) and 5-HT 1A receptor (pK i = 8.5) full agonist (IA = 100%). It also binds to D 4 (pK i = 7.8), α 1 -adrenergic (pK i = 7.8), α 2 -adrenergic (pK i = 7.4), and 5-HT 7 receptors (pK i = 7.2) with lower affinity. Relative to other dopaminergic antiparkinsonian agents, pardoprunox is thought to have significantly less of a propensity for inducing certain side effects like dyskinesia and psychosis. ==See also== List of investigational Parkinson's disease drugs Aripiprazole Bifeprunox ==References== ==Further reading==",
  "categories": [
    "106462793",
    "106462794",
    "108141433",
    "23118434",
    "23468805",
    "23603337",
    "24409354",
    "27236659",
    "27351758",
    "28387434",
    "28698535",
    "43371251",
    "46913180",
    "50769796",
    "60213854",
    "60300459",
    "60367775",
    "61955657",
    "63007578",
    "73736910",
    "73736911",
    "73750205",
    "90826074"
  ],
  "license": "CC BY-SA 4.0",
  "source_uri": "https://en.wikipedia.org/w/index.php?oldid=1338600496",
  "content_hash": "",
  "created_at": null,
  "updated_at": 1771208352.0,
  "claims": [],
  "contradictions": [],
  "confidence": 0.6,
  "csl": {
    "id": "enwiki-001338600496",
    "type": "webpage",
    "title": "Pardoprunox",
    "author": [
      {
        "family": "Anticloud FZ LLE",
        "literal": "Anticloud FZ LLE"
      }
    ],
    "container-title": "encyclopegia.org",
    "publisher": "Anticloud FZ LLE",
    "publisher-place": "Dubai, United Arab Emirates",
    "URL": "https://encyclopegia.org/a/pardoprunox",
    "issued": {
      "date-parts": [
        [
          2026,
          11,
          16
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          2026,
          11,
          16
        ]
      ]
    },
    "license": "CC BY-SA 4.0",
    "DOI": "eo1:enwiki-001338600496",
    "isBasedOn": "https://en.wikipedia.org/w/index.php?oldid=1338600496",
    "note": "Immutable snapshot enwiki-001338600496"
  }
}